Anthrax Lethal Toxin-induced gene expression changes in mouse lung

Toxins

Volumn 3, Issue 9, 2011, Pages 1111-1130

  Dumas, Eric K ^a,b   Cox, Philip M ^b   Fullenwider, Charles O'Connor ^b   Nguyen, Melissa ^a,b   Centola, Michael ^b   Frank, Mark Barton ^b   Dozmorov, Igor ^b   James, Judith A ^a,b   Darise Farris, A ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Gene expression; Lethal Toxin; Lung

Indexed keywords

ANTHRAX LETHAL TOXIN; ANTHRAX TOXIN; CHEMOTAXIS ACTIVATOR; NEUTROPHIL CHEMOATTRACTANT; UNCLASSIFIED DRUG;

A J MOUSE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; C57BL 6 MOUSE; CAPILLARY LEAK SYNDROME; CONTROLLED STUDY; DEATH; DISEASE PREDISPOSITION; EXPOSURE; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GROWTH REGULATION; IMMUNE RESPONSE; LUNG BLOOD VESSEL; LUNG EDEMA; LYMPHOID GENE; MOUSE; MYELOID GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; STRAIN DIFFERENCE; TUMOR GROWTH; UNINDEXED SEQUENCE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; FEMALE; GENE EXPRESSION REGULATION; LETHAL DOSE 50; LUNG; MICE; MICE, INBRED C57BL; SPECIES SPECIFICITY;

ANIMALIA; BACILLUS ANTHRACIS; MUS;

EID: 80053199327     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins3091111     Document Type: Article

References (70)

1. Jernigan, J.A.; Stephens, D.S.; Ashford, D.A.; Omenaca, C.; Topiel, M.S.; Galbraith, M.; Tapper, M.; Fisk, T.L.; Zaki, S.; Popovic, T.; et al. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the united states. Emerg. Infect. Dis. 2001, 7, 933-944.
2. Collier, R.J.; Young, J.A. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 2003, 19, 45-70.
3. van der Goot, G.; Young, J.A. Receptors of anthrax toxin and cell entry. Mol. Aspects Med. 2009, 30, 406-412.
4. Duesbery, N.S.; Webb, C.P.; Leppla, S.H.; Gordon, V.M.; Klimpel, K.R.; Copeland, T.D.; Ahn, N.G.; Oskarsson, M.K.; Fukasawa, K.; Paull, K.D.; et al. Proteolytic inactivation of map-kinase-kinase by anthrax lethal factor. Science 1998, 280, 734-737.
5. Culley, N.C.; Pinson, D.M.; Chakrabarty, A.; Mayo, M.S.; Levine, S.M. Pathophysiological manifestations in mice exposed to anthrax lethal toxin. Infect. Immunol. 2005, 73, 7006-7010.
6. Cui, X.; Moayeri, M.; Li, Y.; Li, X.; Haley, M.; Fitz, Y.; Correa-Araujo, R.; Banks, S.M.; Leppla, S.H.; Eichacker, P.Q. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286, R699-R709.
7. Moayeri, M.; Haines, D.; Young, H.A.; Leppla, S.H. Bacillus anthracis lethal toxin induces tnf-alpha-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 2003, 112, 670-682.
8. Gill, D.M. Bacterial toxins: A table of lethal amounts. Microbiol. Rev. 1982, 46, 86-94.
9. Dixon, T.C.; Meselson, M.; Guillemin, J.; Hanna, P.C. Anthrax. N. Engl. J. Med. 1999, 341, 815-826.
10. Moayeri, M.; Leppla, S.H. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol. Aspects Med. 2009, 30, 439-455.
11. Fang, H.; Xu, L.; Chen, T.Y.; Cyr, J.M.; Frucht, D.M. Anthrax lethal toxin has direct and potent inhibitory effects on b cell proliferation and immunoglobulin production. J. Immunol. 2006, 176, 6155-6161.
12. Comer, J.E.; Chopra, A.K.; Peterson, J.W.; Konig, R. Direct inhibition of t-lymphocyte activation by anthrax toxins in vivo. Infect. Immunol. 2005, 73, 8275-8281.
13. During, R.L.; Li, W.; Hao, B.; Koenig, J.M.; Stephens, D.S.; Quinn, C.P.; Southwick, F.S. Anthrax lethal toxin paralyzes neutrophil actin-based motility. J. Infect. Dis. 2005, 192, 837-845.
14. Warfel, J.M.; Steele, A.D.; D'Agnillo, F. Anthrax lethal toxin induces endothelial barrier dysfunction. Am. J. Pathol. 2005, 166, 1871-1881.
15. Jackson laboratory phenome database. Available online: http://www.jax.org (accessed on 6 September 2011).
16. Salles, II; Voth, D.E.; Ward, S.C.; Averette, K.M.; Tweten, R.K.; Bradley, K.A.; Ballard, J.D. Cytotoxic activity of bacillus anthracis protective antigen observed in a macrophage cell line overexpressing antxr1. Cell. Microbiol. 2006, 8, 1272-1281.
17. Voth, D.E.; Hamm, E.E.; Nguyen, L.G.; Tucker, A.E.; Salles, II; Ortiz-Leduc, W.; Ballard, J.D. Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell. Microbiol. 2005, 7, 1139-1149.
18. Dozmorov, I.; Centola, M. An associative analysis of gene expression array data. Bioinformatics 2003, 19, 204-211.
19. Knowlton, N.; Dozmorov, I.M.; Centola, M. Microarray data analysis toolbox (mdat): For normalization, adjustment and analysis of gene expression data. Bioinformatics 2004, 20, 3687-3690.
20. Dozmorov, I.; Lefkovits, I. Internal standard-based analysis of microarray data. Part 1: Analysis of differential gene expressions. Nucleic Acids Res. 2009, 37, 6323-6339.
21. Dozmorov, M.G.; Guthridge, J.M.; Hurst, R.E.; Dozmorov, I.M. A comprehensive and universal method for assessing the performance of differential gene expression analyses. PLoS One 2010, 5, e12657.
22. Benbrook, D.M.; Lightfoot, S.; Ranger-Moore, J.; Liu, T.; Chengedza, S.; Berry, W.L.; Dozmorov, I. Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention. Gene Regul. Syst. Biol. 2008, 2, 21-42.
23. Torgerson, T.R.; Genin, A.; Chen, C.; Zhang, M.; Zhou, B.; Anover-Sombke, S.; Frank, M.B.; Dozmorov, I.; Ocheltree, E.; Kulmala, P.; et al. Foxp3 inhibits activation-induced nfat2 expression in t cells thereby limiting effector cytokine expression. J. Immunol. 2009, 183, 907-915.
24. Xu, Z.; Potula, H.H.; Vallurupalli, A.; Perry, D.; Baker, H.; Croker, B.P.; Dozmorov, I.; Morel, L. Cyclin-dependent kinase inhibitor cdkn2c regulates b cell homeostasis and function in the nzm2410-derived murine lupus susceptibility locus sle2c1. J. Immunol. 2011, 186, 6673-6682.
25. Bioconductor diffgeneanalysis. Available online: http://www.bioconductor.org/packages/2.5/bioc/html/diffGeneAnalysis.html (accessed on 6 September).
26. Moayeri, M.; Martinez, N.W.; Wiggins, J.; Young, H.A.; Leppla, S.H. Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect. Immun. 2004, 72, 4439-4447.
27. Boyden, E.D.; Dietrich, W.F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 2006, 38, 240-244.
28. Edgar, R.; Domrachev, M.; Lash, A.E. Gene expression omnibus: Ncbi gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30, 207-210.
29. Ncbi gene expression omnibus. Available online; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE28554 (accessed on 7 September 2011).
30. Pai, J.T.; Ruoslahti, E. Identification of endothelial genes up-regulated in vivo. Gene 2005, 347, 21-33.
31. Favre, C.J.; Mancuso, M.; Maas, K.; McLean, J.W.; Baluk, P.; McDonald, D.M. Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H1917-1938.
32. Rouleau, C.; Menon, K.; Boutin, P.; Guyre, C.; Yoshida, H.; Kataoka, S.; Perricone, M.; Shankara, S.; Frankel, A.E.; Duesbery, N.S.; et al. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: Assessment of receptor contribution. Int. J. Oncol. 2008, 32, 739-748.
33. Kitamura, K.; Kangawa, K.; Kawamoto, M.; Ichiki, Y.; Nakamura, S.; Matsuo, H.; Eto, T. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 1993, 192, 553-560.
34. Mutlu, G.M.; Dumasius, V.; Burhop, J.; McShane, P.J.; Meng, F.J.; Welch, L.; Dumasius, A.; Mohebahmadi, N.; Thakuria, G.; Hardiman, K.; et al. Upregulation of alveolar epithelial active na+ transport is dependent on beta2-adrenergic receptor signaling. Circ. Res. 2004, 94, 1091-1100.
35. Factor, P.; Adir, Y.; Mutlu, G.M.; Burhop, J.; Dumasius, V. Effects of beta2-adrenergic receptor overexpression on alveolar epithelial active transport. J. Allergy Clin. Immunol. 2002, 110, S242-246.
36. Tang, K.M.; Wang, G.R.; Lu, P.; Karas, R.H.; Aronovitz, M.; Heximer, S.P.; Kaltenbronn, K.M.; Blumer, K.J.; Siderovski, D.P.; Zhu, Y.; et al. Regulator of g-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat. Med. 2003, 9, 1506-1512.
37. Kirby, J.E. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 2004, 72, 430-439.
38. Gozes, Y.; Moayeri, M.; Wiggins, J.F.; Leppla, S.H. Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice. Infect. Immun. 2006, 74, 1266-1272.
39. Okuda, J.; Arikawa, Y.; Takeuchi, Y.; Mahmoud, M.M.; Suzaki, E.; Kataoka, K.; Suzuki, T.; Okinaka, Y.; Nakai, T. Intracellular replication of edwardsiella tarda in murine macrophage is dependent on the type iii secretion system and induces an up-regulation of anti-apoptotic nf-kappab target genes protecting the macrophage from staurosporine-induced apoptosis. Microb. Pathog. 2006, 41, 226-240.
40. van Hinsbergh, V.W.; van Nieuw Amerongen, G.P. Intracellular signalling involved in modulating human endothelial barrier function. J. Anat. 2002, 200, 549-560.
41. Arora, N.; Leppla, S.H. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J. Biol. Chem. 1993, 268, 3334-3341.
42. Duesbery, N.S.; Resau, J.; Webb, C.P.; Koochekpour, S.; Koo, H.M.; Leppla, S.H.; Vande Woude, G.F. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple mek pathways. Proc. Natl. Acad. Sci. USA 2001, 98, 4089-4094.
43. Alfano, R.W.; Leppla, S.H.; Liu, S.; Bugge, T.H.; Ortiz, J.M.; Lairmore, T.C.; Duesbery, N.S.; Mitchell, I.C.; Nwariaku, F.; Frankel, A.E. Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinoma. Mol. Cancer Ther. 2010, 9, 190-201.
44. Pliyev, B.K.; Antonova, O.A.; Menshikov, M. Participation of the urokinase-type plasminogen activator receptor (upar) in neutrophil transendothelial migration. Mol. Immunol. 2011, 48, 1168-1177.
45. Rijneveld, A.W.; Levi, M.; Florquin, S.; Speelman, P.; Carmeliet, P.; van Der Poll, T. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J. Immunol. 2002, 168, 3507-3511.
46. Gyetko, M.R.; Sud, S.; Kendall, T.; Fuller, J.A.; Newstead, M.W.; Standiford, T.J. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary pseudomonas aeruginosa infection. J. Immunol. 2000, 165, 1513-1519.
47. Ridger, V.C.; Wagner, B.E.; Wallace, W.A.; Hellewell, P.G. Differential effects of cd18, cd29, and cd49 integrin subunit inhibition on neutrophil migration in pulmonary inflammation. J. Immunol. 2001, 166, 3484-3490.
48. Moen, S.T.; Yeager, L.A.; Lawrence, W.S.; Ponce, C.; Galindo, C.L.; Garner, H.R.; Baze, W.B.; Suarez, G.; Peterson, J.W.; Chopra, A.K. Transcriptional profiling of murine organ genes in response to infection with bacillus anthracis ames spores. Microb. Pathog. 2008, 44, 293-310.
49. Heximer, S.P.; Knutsen, R.H.; Sun, X.; Kaltenbronn, K.M.; Rhee, M.H.; Peng, N.; Oliveira-dos-Santos, A.; Penninger, J.M.; Muslin, A.J.; Steinberg, T.H.; et al. Hypertension and prolonged vasoconstrictor signaling in rgs2-deficient mice. J. Clin. Invest. 2003, 111, 445-452.
50. Cui, X.; Li, Y.; Moayeri, M.; Choi, G.H.; Subramanian, G.M.; Li, X.; Haley, M.; Fitz, Y.; Feng, J.; Banks, S.M.; et al. Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis. J. Infect. Dis. 2005, 191, 422-434.
51. Siderovski, D.P.; Heximer, S.P.; Forsdyke, D.R. A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mrna increases rapidly in cycloheximide-treated blood mononuclear cells. DNA Cell Biol. 1994, 13, 125-147.
52. Kato, H.; Shichiri, M.; Marumo, F.; Hirata, Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 1997, 138, 2615-2620.
53. Di Paola, R.; Talero, E.; Galuppo, M.; Mazzon, E.; Bramanti, P.; Motilva, V.; Cuzzocrea, S. Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis. Respir. Res. 2011, 12, 41.
54. Kennedy, S.P.; Sun, D.; Oleynek, J.J.; Hoth, C.F.; Kong, J.; Hill, R.J. Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response. Biochem. Biophys. Res. Commun. 1998, 244, 832-837.
55. Ramachandran, V.; Arumugam, T.; Langley, R.; Hwang, R.F.; Vivas-Mejia, P.; Sood, A.K.; Lopez-Berestein, G.; Logsdon, C.D. The admr receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment. PLoS One 2009, 4, e7502.
56. Crandall, E.D.; Heming, T.A.; Palombo, R.L.; Goodman, B.E. Effects of terbutaline on sodium transport in isolated perfused rat lung. J. Appl. Physiol. 1986, 60, 289-294.
57. Frank, J.A.; Wang, Y.; Osorio, O.; Matthay, M.A. Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats. J. Appl. Physiol. 2000, 89, 1255-1265.
58. Bogatcheva, N.V.; Verin, A.D. The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc. Res. 2008, 76, 202-207.
59. Friedlander, A.M. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 1986, 261, 7123-7126.
60. Friedlander, A.M.; Bhatnagar, R.; Leppla, S.H.; Johnson, L.; Singh, Y. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect. Immun. 1993, 61, 245-252.
61. Liu, S.; Miller-Randolph, S.; Crown, D.; Moayeri, M.; Sastalla, I.; Okugawa, S.; Leppla, S.H. Anthrax toxin targeting of myeloid cells through the cmg2 receptor is essential for establishment of bacillus anthracis infections in mice. Cell Host Microbe 2010, 8, 455-462.
62. Barson, H.V.; Mollenkopf, H.; Kaufmann, S.H.; Rijpkema, S. Anthrax lethal toxin suppresses chemokine production in human neutrophil nb-4 cells. Biochem. Biophys. Res. Commun. 2008, 374, 288-293.
63. St Croix, B.; Rago, C.; Velculescu, V.; Traverso, G.; Romans, K.E.; Montgomery, E.; Lal, A.; Riggins, G.J.; Lengauer, C.; Vogelstein, B.; et al. Genes expressed in human tumor endothelium. Science 2000, 289, 1197-1202.
64. 2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells. Am. J. Physiol. Cell Physiol. 2011, 300, C266-C275.
65. Malla, R.R.; Gopinath, S.; Gondi, C.S.; Alapati, K.; Dinh, D.H.; Gujrati, M.; Rao, J.S. Cathepsin b and upar knockdown inhibits tumor-induced angiogenesis by modulating vegf expression in glioma. Cancer Gene Ther. 2011, 18, 419-434.
66. Paccani, S.R.; Tonello, F.; Ghittoni, R.; Natale, M.; Muraro, L.; D'Elios, M.M.; Tang, W.J.; Montecucco, C.; Baldari, C.T. Anthrax toxins suppress t lymphocyte activation by disrupting antigen receptor signaling. J. Exp. Med. 2005, 201, 325-331.
67. Hirsh, M.I.; Manov, I.; Cohen-Kaplan, V.; Iancu, T.C. Ultrastructural features of lymphocyte suppression induced by anthrax lethal toxin and treated with chloroquine. Lab. Invest. 2007, 87, 182-188.
68. Guidi-Rontani, C.; Duflot, E.; Mock, M. Anthrax lethal toxin-induced mitogenic response of human t-cells. FEMS Microbiol. Lett. 1997, 157, 285-289.
69. Rosenstein, M.; Ettinghausen, S.E.; Rosenberg, S.A. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J. Immunol. 1986, 137, 1735-1742.
70. Puri, R.K.; Rosenberg, S.A. Combined effects of interferon alpha and interleukin 2 on the induction of a vascular leak syndrome in mice. Cancer Immunol. Immunother. 1989, 28, 267-274.